Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Medtronic logoMedtronic MDT

The company said it held its October 17, 2024 2024 Annual General Meeting of Shareholders to address 6 proposals, including electing 10 directors, approving the appointment of the auditor, holding a non-binding advisory vote on executive pay, renewing authority to issue shares and to opt out of pre-emption rights, and approving overseas market purchases of ordinary shares.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The company said it held its October 17, 2024 2024 Annual General Meeting of Shareholders to address 6 proposals, including electing 10 directors, approving the appointment of the auditor, holding a non-binding advisory vote on executive pay, renewing authority to issue shares and to opt out of pre-emption rights, and approving overseas market purchases of ordinary shares.

  2. The company said that as of the close of business on August 23, 2024, the record date, 1,282,467,348 ordinary shares were outstanding and entitled to vote. It said 1,118,364,589 shares were present at the meeting, either in person or by proxy, meeting the quorum requirement.

  3. The company said all 10 director nominees were elected. Craig Arnold received 952,980,300 votes for, 45,113,878 against and 1,927,552 abstentions. Kendall J. Powell received 906,406,435 votes for, 91,375,803 against and 2,239,492 abstentions.

  4. The company said shareholders approved the appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal 2025, with 1,008,653,733 votes for and 107,729,791 against. The non-binding advisory vote on executive pay was approved, with 924,541,222 votes for and 70,301,925 against.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

2024 Annual General Meeting of Shareholders Held and Proposals Voted On

The company said it held its October 17, 2024 2024 Annual General Meeting of Shareholders to address 6 proposals, including electing 10 directors, approving the appointment of the auditor, holding a non-binding advisory vote on executive pay, renewing authority to issue shares and to opt out of pre-emption rights, and approving overseas market purchases of ordinary shares.

Source · Based on the filing body and exhibits

Ordinary Shares Entitled to Vote and Quorum Met

The company said that as of the close of business on August 23, 2024, the record date, 1,282,467,348 ordinary shares were outstanding and entitled to vote. It said 1,118,364,589 shares were present at the meeting, either in person or by proxy, meeting the quorum requirement.

Source · Based on the filing body and exhibits

All 10 Director Nominees Elected

The company said all 10 director nominees were elected. Craig Arnold received 952,980,300 votes for, 45,113,878 against and 1,927,552 abstentions. Kendall J. Powell received 906,406,435 votes for, 91,375,803 against and 2,239,492 abstentions.

Source · Based on the filing body and exhibits

Auditor Appointment and Executive Pay Advisory Vote Results

The company said shareholders approved the appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal 2025, with 1,008,653,733 votes for and 107,729,791 against. The non-binding advisory vote on executive pay was approved, with 924,541,222 votes for and 70,301,925 against.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.